EICHORCondition: Catheter-based Ablation of Atrial Fibrillation · Sponsor: University Hospital, Basel, Switzerland
Interested? Contact the study team ↓
Registry of patients with atrial fibrillation undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation) to determine long-term success rates of catheter-based ablation of atrial fibrillation (pulmonary vein isolation) and to evaluate factors associated with long-term success of catheter-based ablation of atrial fibrillation (pulmonary vein isolation).
This description comes directly from the study's public registry record.
Michael Kuehne, MD · +41 61 328 74 71 · michael.kuehne@usb.ch
Gian Voellmin, MSc · +41 61 556 52 96 · gian.voellmin@usb.ch
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * patients undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation) Exclusion Criteria: * Patients not able or willing to participate in this study
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Cardiology/Electrophysiology, University Hospital Basel | Basel, Switzerland | Recruiting |
| University Hospital Bern | Bern, Switzerland | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03718364